Foresight Diagnostics
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Colorado, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
12705 E Montview Blvd Ste 360, Aurora, C...Website
www.foresight-dx.comRevenue
$6.8 MillionIndustry
About Foresight Diagnostics
Foresight Diagnostics is a privately-held cancer diagnostics company. The company has developed a novel liquid biopsy testing platform for the measurement of minimal residual disease (MRD) that is broadly applicable to a variety of cancers and that is significantly more sensitive than existing tests (with a detection limit below 0.0001% or one part-per-million). This improved sensitivity provides actionable information to physicians and biopharmaceutical companies to enable more personalized treatment approaches for patients.Explore more
Foresight Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Foresight Diagnostics
Compare insights from companies similar to Foresight Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Foresight Diagnostics
$6.8M
51-200
Private
$104.3M
2020
RG
Ruben GutierrezSenior Vice President and General Counsel
Foresight Diagnostics Tech Stack
A closer look at the technologies used by Foresight Diagnostics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Foresight Diagnostics
Sign Up For FreeTo access detailed company insights
Foresight Diagnostics is a privately-held cancer diagnostics company. The company has developed a novel liquid biopsy testing platform for the measurement of minimal residual disease (MRD) that is broadly applicable to a variety of cancers and that is significantly more sensitive than existing tests (with a detection limit below 0.0001% or one part... Read More
